Visit COVID-19 resources

[Skip to Content]

Eye Journal

Elevated neutrophil-to-lymphocyte ratio in pseudoexfoliation syndrome – (Eye 30, 1045 (August 2016))

Aug 11
2016

Elevated neutrophil-to-lymphocyte ratio in pseudoexfoliation syndrome Eye 30, 1045 (August 2016). doi:10.1038/eye.2016.89 Authors: B E Kurtul, P A Ozer & E U Kabatas

  • 11 August 2016

Wrong intraocular lens events—what lessons have we learned? A review of incidents reported to the National Reporting and Learning System: 2010–2014 versus 2003–2010 – (Eye 30, 1049 (August 2016))

Aug 11
2016

Wrong intraocular lens events—what lessons have we learned? A review of incidents reported to the National Reporting and Learning System: 2010–2014 versus 2003–2010 Eye 30, 1049 (August 2016). doi:10.1038/eye.2016.87 Authors: L R Steeples, M Hingorani, D Flanagan & S P Kelly

  • 11 August 2016

Comparison of botulinum toxin-A injection in lacrimal gland and conjunctivodacryocystorhinostomy for treatment of epiphora due to proximal lacrimal system obstruction – (Eye 30, 1056 (August 2016))

Aug 11
2016

Comparison of botulinum toxin-A injection in lacrimal gland and conjunctivodacryocystorhinostomy for treatment of epiphora due to proximal lacrimal system obstruction Eye 30, 1056 (August 2016). doi:10.1038/eye.2016.88 Authors: P Kaynak, G O Karabulut, C Ozturker, K Fazil, Y O Arat, I Perente, S Akar, O F Yilmaz & A Demirok

  • 11 August 2016

Determinants of visual acuity outcomes in eyes with neovascular AMD treated with anti-VEGF agents: an instrumental variable analysis of the AURA study – (Eye 30, 1063 (August 2016))

Aug 11
2016

Determinants of visual acuity outcomes in eyes with neovascular AMD treated with anti-VEGF agents: an instrumental variable analysis of the AURA study Eye 30, 1063 (August 2016). doi:10.1038/eye.2016.90 Authors: F G Holz, R Tadayoni, S Beatty, A R Berger, M G Cereda, P Hykin, G Staurenghi, K Wittrup-Jensen, J Nilsson, K Kim & S Sivaprasad

  • 11 August 2016

Variability of disease activity in patients treated with ranibizumab for neovascular age-related macular degeneration – (Eye 30, 1072 (August 2016))

Aug 11
2016

Variability of disease activity in patients treated with ranibizumab for neovascular age-related macular degeneration Eye 30, 1072 (August 2016). doi:10.1038/eye.2016.97 Authors: P Enders, P Scholz, P S Muether & S Fauser

  • 11 August 2016